A novel pathogenic variant in MYO18B associating early-onset muscular hypotonia, and characteristic dysmorphic features, delineation of the phenotypic spectrum of MYO18B-related conditions.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
05 Jun 2020
Historique:
received: 11 10 2019
revised: 07 02 2020
accepted: 08 03 2020
pubmed: 19 3 2020
medline: 2 6 2020
entrez: 19 3 2020
Statut: ppublish

Résumé

Homozygous loss-of-function variants in MYO18B have been associated with congenital myopathy, facial dysmorphism and Klippel-Feil anomaly. So far, only four patients have been reported. Comprehensive description of new cases that help to highlight recurrent features and to further delineate the phenotypic spectrum are still missing. We present the fifth case of MYO18B-associated disease in a newborn male patient. Trio exome sequencing identified the previously unreported homozygous nonsense variant c.6433C>T, p.(Arg2145*) in MYO18B (NM_032608.5). While most phenotypic features of our patient align with previously reported cases, we describe the prenatal features for the first time. Taking the phenotypic description of our patient into account, we propose that the core phenotype comprises a severe congenital myopathy with feeding difficulties in infancy and characteristic dysmorphic features.

Identifiants

pubmed: 32184166
pii: S0378-1119(20)30211-0
doi: 10.1016/j.gene.2020.144542
pii:
doi:

Substances chimiques

MYO18B protein, human 0
Tumor Suppressor Proteins 0
Myosins EC 3.6.4.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144542

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Theresa Brunet (T)

Institute of Human Genetics, Technical University of Munich, Munich, Germany. Electronic address: theresa.brunet@mri.tum.de.

Dominik S Westphal (DS)

Institute of Human Genetics, Technical University of Munich, Munich, Germany.

Sandrina Weber (S)

Institute of Neurogenomics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Hendrik Juenger (H)

Department of Pediatrics, Technical University of Munich, Munich, Germany.

Stefan Vlaho (S)

Department of Pediatrics, Altoetting-Burghausen, Altoetting, Germany.

Julia Hoefele (J)

Institute of Human Genetics, Technical University of Munich, Munich, Germany.

Thomas Meitinger (T)

Institute of Human Genetics, Technical University of Munich, Munich, Germany.

Esther Rieger-Fackeldey (E)

Department of Pediatrics, Technical University of Munich, Munich, Germany.

Matias Wagner (M)

Institute of Human Genetics, Technical University of Munich, Munich, Germany; Institute of Neurogenomics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH